Technical, angiographic and clinical outcomes of Neuroform 1, 2, 2 Treo and 3 devices in stent-assisted coiling of intracranial aneurysms.

@article{Kadkhodayan2012TechnicalAA,
  title={Technical, angiographic and clinical outcomes of Neuroform 1, 2, 2 Treo and 3 devices in stent-assisted coiling of intracranial aneurysms.},
  author={Yasha Kadkhodayan and Christopher T Somogyi and D T Cross and Colin P Derdeyn and Gregory Joseph Zipfel and Michael Chicoine and Keith M. Rich and Robert L. Grubb and Ralph Dacey and C J Moran},
  journal={Journal of neurointerventional surgery},
  year={2012},
  volume={4 5},
  pages={368-74}
}
BACKGROUND AND PURPOSE Since 2002 the Neuroform stent has expanded endovascular treatment of wide-necked intracranial aneurysms. A study was undertaken to assess the technical success rates and angiographic and clinical outcomes in stent-assisted coiling with Neuroform 1, 2, 2 Treo and 3. METHODS Patients undergoing Neuroform stent-assisted coiling were enrolled in a prospective registry that included 156 stent deployment attempts in 113 consecutive patients (mean age 53, range 25-78… CONTINUE READING

Connections & Topics

Mentioned Connections BETA
Of 156 stent attempts , 123 ( 79% ) were deployed ( Neuroform 1 : 8/9 ( 89% ) , Neuroform 2 : 50/66 ( 76% ) , Neuroform 2 Treo : 9/11 ( 82% ) , Neuroform 3 : 56/70 ( 80% ) ) with a symptomatic complication rate of 1.9% ( 3/156 ; 2 transient ischemic attacks , 1 stroke , no deaths ) .
Of 156 stent attempts , 123 ( 79% ) were deployed ( Neuroform 1 : 8/9 ( 89% ) , Neuroform 2 : 50/66 ( 76% ) , Neuroform 2 Treo : 9/11 ( 82% ) , Neuroform 3 : 56/70 ( 80% ) ) with a symptomatic complication rate of 1.9% ( 3/156 ; 2 transient ischemic attacks , 1 stroke , no deaths ) .
Of 156 stent attempts , 123 ( 79% ) were deployed ( Neuroform 1 : 8/9 ( 89% ) , Neuroform 2 : 50/66 ( 76% ) , Neuroform 2 Treo : 9/11 ( 82% ) , Neuroform 3 : 56/70 ( 80% ) ) with a symptomatic complication rate of 1.9% ( 3/156 ; 2 transient ischemic attacks , 1 stroke , no deaths ) .
Of 156 stent attempts , 123 ( 79% ) were deployed ( Neuroform 1 : 8/9 ( 89% ) , Neuroform 2 : 50/66 ( 76% ) , Neuroform 2 Treo : 9/11 ( 82% ) , Neuroform 3 : 56/70 ( 80% ) ) with a symptomatic complication rate of 1.9% ( 3/156 ; 2 transient ischemic attacks , 1 stroke , no deaths ) .
Deployment success and difficulty , stent movement , procedural complications , immediate / delayed aneurysm occlusion and in - stent stenosis on angiographic follow - up were compared among Neuroform 1 , 2 , 2 Treo and 3 stents using a log likelihood ratio χ2 test .
Deployment success and difficulty , stent movement , procedural complications , immediate / delayed aneurysm occlusion and in - stent stenosis on angiographic follow - up were compared among Neuroform 1 , 2 , 2 Treo and 3 stents using a log likelihood ratio χ2 test .
Of 156 stent attempts , 123 ( 79% ) were deployed ( Neuroform 1 : 8/9 ( 89% ) , Neuroform 2 : 50/66 ( 76% ) , Neuroform 2 Treo : 9/11 ( 82% ) , Neuroform 3 : 56/70 ( 80% ) ) with a symptomatic complication rate of 1.9% ( 3/156 ; 2 transient ischemic attacks , 1 stroke , no deaths ) .
Of 156 stent attempts , 123 ( 79% ) were deployed ( Neuroform 1 : 8/9 ( 89% ) , Neuroform 2 : 50/66 ( 76% ) , Neuroform 2 Treo : 9/11 ( 82% ) , Neuroform 3 : 56/70 ( 80% ) ) with a symptomatic complication rate of 1.9% ( 3/156 ; 2 transient ischemic attacks , 1 stroke , no deaths ) .
Of 156 stent attempts , 123 ( 79% ) were deployed ( Neuroform 1 : 8/9 ( 89% ) , Neuroform 2 : 50/66 ( 76% ) , Neuroform 2 Treo : 9/11 ( 82% ) , Neuroform 3 : 56/70 ( 80% ) ) with a symptomatic complication rate of 1.9% ( 3/156 ; 2 transient ischemic attacks , 1 stroke , no deaths ) .
All Topics